U.S. Medical Equipment Stock News

The Morning Bull - US Market Morning Update Wednesday, May, 27 2026 US stock futures are pointing higher this morning, with contracts linked to the S&P 500 and Nasdaq 100 up around 0.5% to 0.8%, as investors weigh stronger global growth signals against rising interest rate pressures. In Taiwan, retail sales are up 5.2% over the past year and industrial production is 14.16% higher, hinting at steady demand for electronics and other goods that feed into US tech and chip stocks. At the same...

Northwest Bancshares (NasdaqGS:NWBI) has appointed Chad Ballard as Chief Information Officer. Ballard brings extensive experience from large financial institutions to the bank's technology leadership team. The CIO appointment reflects the growing importance of digital capabilities and information security in banking. For a regional banking company like Northwest Bancshares, technology is now central to how customers access services, including mobile apps and online account management...

Guardant Health (NasdaqGS:GH) received FDA approval for its Guardant360 Liquid CDx test, described as the most comprehensive blood-based cancer profiling test integrating genomic and epigenomic data. The approval covers advanced cancer care and expands the test's use as a companion diagnostic across multiple cancer types. The platform uses AI-enabled multiomic technology to combine genomic and epigenomic insights in a single liquid biopsy. Guardant Health focuses on liquid biopsy...

If you are wondering whether MercadoLibre stock still justifies its current price, the key question is how that price stacks up against the value implied by its fundamentals. The shares last closed at US$1,648.04, with the price rising about 3.3% over the past week but declining around 10.2% over the past month and about 16.5% year to date, while the return over the past year is a decline of roughly 35.5% and the 3 and 5 year returns are about 31.9% and 20.4% respectively. These moves have...

Satellogic Inc. recently announced it secured a one-year contract worth more than US$18,000,000 with an international defense customer for persistent, high-frequency Earth observation imagery using its NewSat constellation. This rapid shift from a short trial to full-scale deployment in under six months highlights growing defense demand for subscription-style, high-cadence geospatial intelligence services. We’ll now examine how this major US$18,000,000 defense imagery contract influences...

Natera (NasdaqGS:NTRA) announced a major upgrade to its Panorama non-invasive prenatal test that targets long-standing issues with low fetal fraction samples. The company also secured FDA approval for Signatera CDx as the first blood-based minimal residual disease companion diagnostic for guiding immunotherapy in muscle-invasive bladder cancer. Natera operates across prenatal screening and oncology testing, so these two updates touch both core parts of the business at the same time. The...

Why Southwest’s robot ban matters for LUV investors Southwest Airlines (LUV) has introduced a new policy banning humanoid and animal-like robots on its flights. The airline is focusing on fire risks tied to large lithium-ion batteries, while keeping everyday personal electronics unaffected. See our latest analysis for Southwest Airlines. The new robot ban comes as LUV’s 1 day share price return of 3.48% and 7 day share price return of 13.20% follow its recent US$1.5b term loan agreement. Over...

Garmin (GRMN) is back in focus after stronger than expected late April earnings and the launch of its new Forerunner 70 and Forerunner 170 running watches, drawing fresh attention to the stock. See our latest analysis for Garmin. The recent launch of the new Forerunner models and stronger than expected April earnings appear to have supported sentiment. Garmin’s share price is up 17.8% year to date despite being down 8.0% over the past month, while the 3 year total shareholder return of 139.3%...

A sharp drop in WTI crude prices has put Cheesecake Factory (CAKE) back in focus, as cheaper fuel eases consumer gas bills while potentially trimming the company’s transportation and operating costs. See our latest analysis for Cheesecake Factory. Cheesecake Factory’s recent 5.7% 1-day share price return and 10.5% 7-day share price return suggest momentum has picked up again, even though the 90-day share price return is slightly down 2%. The 3-year total shareholder return of 116.7%...

ADT (ADT) is drawing attention after recent trading left the stock around $6.93, with performance down over the past month and past 3 months, despite the company reporting revenue of about $5.14b and net income of $627.39m. See our latest analysis for ADT. At a share price of $6.93, ADT’s recent 7 day share price gain has not offset a weaker trend. The 30 day share price return is down 4.55% and the year to date share price return is down 13.48%, while the 3 year total shareholder return is...

Recent commentary on Stryker (SYK) has focused on mixed Q1 results, trimmed price targets, and questions around full year guidance, even as the company manages margin pressure, a cybersecurity incident, and fresh product launches. See our latest analysis for Stryker. The share price has come off its highs, with a 90 day share price return down 18.5% and year to date share price return down 10.1%. However, the 3 year total shareholder return of 18.69% and 5 year total shareholder return of...

Wondering if Napco Security Technologies at US$37.09 still offers value after its recent run? This article walks through what the current price might be implying about the stock. The stock is up 3.5% over the past week, but down 19.2% over the past month and down 10.4% year to date. It still shows a 32.9% gain over the last year and 1.9% over three years, with a 133.2% return over five years. Recent news coverage has focused on Napco Security Technologies as investors reassess growth...

Avista (AVA) is on investors’ radar after recent share price moves, with the stock last closing at $41.50. That puts the company’s market value around $3.4b, anchoring any assessment of its current valuation. See our latest analysis for Avista. Recent moves sit within a steadier trend, with a 90 day share price return of 2.19% and a year to date share price return of 7.18% alongside a 1 year total shareholder return of 12.27%. This points to gradually building momentum rather than a sharp re...

Earlier this month, Hims & Hers Health, Inc. launched access to generic semaglutide in Canada through its virtual platform, offering personalised GLP-1-based weight management plans starting at C$149 per month alongside ongoing support from Canadian providers. This move expands the company’s GLP-1 footprint into a large Canadian population living with overweight or obesity, while pairing lower-cost generics with branded options and comprehensive lifestyle resources to potentially deepen...

Medtronic stock reacts to sustained share price pressure Medtronic (MDT) has come under pressure recently, with the stock down about 7% over the past month and roughly 20% over the past 3 months. This has prompted closer attention to its valuation and fundamentals. See our latest analysis for Medtronic. At a share price of US$77.60, Medtronic's recent pressure adds to a year-to-date share price return that is down about 19%, while the 1-year total shareholder return is close to flat and the...

If you are wondering whether NiSource at around US$47.80 is priced for more growth or already reflects high expectations, the starting point is understanding what the current market price is implying about its value. The stock has delivered a 0.8% gain over the last 7 days, is down 0.4% over the past month, and has returns of 13.4% year to date, 24.9% over 1 year, 97.7% over 3 years and 121.6% over 5 years, which may influence how much future upside or downside investors see from...

Officer exculpation proposal and upcoming earnings put Braze in focus Braze (BRZE) is back on investor radars after scheduling an annual meeting to vote on officer exculpation under updated Delaware law, just as the company prepares to report quarterly earnings after Wednesday’s market close. See our latest analysis for Braze. At a share price of US$25.45, Braze has seen strong short term momentum, with a 7 day share price return of 16.96% and a 90 day share price return of 44.68%. However,...

Leadership change in CSX's technology function CSX (CSX) has announced the immediate departure of Executive Vice President and Chief Digital & Technology Officer Stephen Fortune, and Steve Watkins will take over these responsibilities effective immediately. See our latest analysis for CSX. CSX's share price has recently moved higher, with a 1 day share price return of 2.39% and a 90 day share price return of 10.40%. Its 1 year total shareholder return of 50.56% points to momentum that has...

Lemonade’s latest earnings reset expectations for this AI-driven insurer Lemonade (LMND) is back in focus after its Q1 2026 earnings update, which featured 71% revenue growth, a 62% gross loss ratio, and guidance targeting positive adjusted EBITDA by Q4 2026. The company also highlighted its use of AI across onboarding, quoting, and claims, and pointed to a 6% loss adjustment expense ratio that may interest investors weighing these operational gains against catastrophe risk and growing...

Willdan Group (WLDN) has drawn investor attention after a period of mixed share performance, with the stock up over the past month but lower over the past 3 months and year to date. See our latest analysis for Willdan Group. At a share price of $93.17, Willdan Group’s recent 30 day share price return of 19.53% contrasts with a 90 day decline of 20.44%. The 3 year total shareholder return of about 4.5x indicates that long term holders have seen much stronger gains, and current momentum appears...

Teleflex (TFX) has drawn fresh attention after releasing new clinical results for its Interventional Urology products, the UroLift System and Barrigel rectal spacer, at the AUA and ESTRO 2026 congresses, highlighting patient-centered outcomes. See our latest analysis for Teleflex. Teleflex’s recent Interventional Urology data and dividend affirmation come as the stock trades at US$131.89, with the share price up 17.87% over 90 days but long term total shareholder returns still well below five...

Thermon Group Holdings, Inc. recently reported its fourth-quarter and full-year results to March 31, 2026, with sales rising to US$148.33 million for the quarter and US$536.26 million for the year, while net income fell to US$2.75 million and US$44.57 million respectively compared with the prior year. The combination of higher revenue but lower net income and earnings per share highlights pressure on profitability even as Thermon continues to grow its top line. We’ll now examine how...

Flowers Foods (FLO) is back on investors’ radar after a busy earnings update, combining Q1 results, a reset dividend, and fresh 2026 guidance with a high profile relaunch of its flagship Nature’s Own brand. See our latest analysis for Flowers Foods. Despite a brief 7 day share price rebound of 8.04% following the Q1 earnings beat, dividend reset and Nature’s Own relaunch, Flowers Foods’ share price return is still down 27.80% year to date and the 1 year total shareholder return is down...

If you are wondering whether Mosaic at US$22.62 is a potential bargain or a value trap, this article walks through what the current share price might be implying about the stock. The stock has risen 5.7% over the last week, but is still down 5.8% over the past month, down 9.6% year to date and down 34.7% over the last year. These moves may have shifted how the market views its risk and return trade off. Recent coverage of Mosaic has focused on its position within the broader materials and...